Three projects (with a total value of £0.3 million) are directly concerned with Phase I trials ie the first stage of testing newly researched treatments, including drugs, on patients.The Executive's recent contribution of £1 million per annum to support the clinical trial infrastructure required to facilitate patient entry into clinical trials in Scotland, ...